Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$33,842,057
+$6,057,275 QoQ
Shares Held
134,486
+5.3% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
16.62%
of 13F equity value
Holder Rank
#104
of 1,872 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 1%
Shared 0%
None 99%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TSFG, LLC holds $36,697,261 across 15 Drug Manufacturers - General names. ABBV ranks #1 (92.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
134,486 | $33,842,057 | |
| 2 | LLY |
ELI LILLY & Co
|
962 | $1,153,851 | |
| 3 | JNJ |
Johnson & Johnson
|
2,996 | $760,894 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,866 | $239,781 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
1,324 | $167,274 | |
| 6 | AMGN |
Amgen Inc
|
330 | $119,499 | |
| 7 | PFE |
Pfizer Inc
|
4,874 | $117,365 | |
| 8 | AZN |
Astrazeneca PLC
|
573 | $108,652 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,842,057 | 134,486 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $27,784,782 | 127,752 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $28,457,744 | 124,547 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $28,579,445 | 123,432 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $22,308,182 | 120,182 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $24,383,937 | 116,380 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $20,356,245 | 114,554 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $20,673,786 | 104,688 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $18,236,006 | 106,320 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $19,393,103 | 106,497 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $19,436,492 | 125,421 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $19,074,462 | 127,965 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $16,792,881 | 124,641 | Shares | Sole | 2023-07-10 | |
| 2023-03-31 | $19,715,503 | 123,709 | Shares | Sole | 2023-04-21 | |
| 2022-12-31 | $20,264,439 | 125,391 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $16,201,965 | 120,721 | Shares | Sole | 2022-10-20 | |
| 2022-06-30 | $17,525,026 | 114,423 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $19,340,533 | 119,305 | Shares | Sole | 2022-04-25 | |
| 2021-12-31 | $16,521,643 | 122,021 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $11,872,495 | 110,063 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $11,671,418 | 103,617 | Shares | Sole | 2021-07-19 | |
| 2021-03-31 | $10,886,282 | 100,594 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $10,436,945 | 97,405 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $8,666,417 | 98,943 | Shares | Sole | 2020-10-06 | |
| 2020-06-30 | $8,390,953 | 85,465 | Shares | Sole | 2020-07-07 | |
| 2020-03-31 | $5,601,412 | 73,519 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||